mRNA癌ワクチン・治療薬の世界市場（～2026年）

• 英文タイトル：Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03858 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はmRNA癌ワクチン・治療薬のグローバル市場について調査・分析したレポートです。種類別（腺癌、粘液性癌、腺扁平上皮癌）市場規模、用途別（感染症、がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別mRNA癌ワクチン・治療薬の競争状況、市場シェア ・世界のmRNA癌ワクチン・治療薬市場：種類別市場規模 2015年-2020年（腺癌、粘液性癌、腺扁平上皮癌） ・世界のmRNA癌ワクチン・治療薬市場：種類別市場規模予測 2021年-2026年（腺癌、粘液性癌、腺扁平上皮癌） ・世界のmRNA癌ワクチン・治療薬市場：用途別市場規模 2015年-2020年（感染症、がん、その他） ・世界のmRNA癌ワクチン・治療薬市場：用途別市場規模予測 2021年-2026年（感染症、がん、その他） ・北米のmRNA癌ワクチン・治療薬市場分析：米国、カナダ ・ヨーロッパのmRNA癌ワクチン・治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのmRNA癌ワクチン・治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のmRNA癌ワクチン・治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのmRNA癌ワクチン・治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Market Analysis and Insights: Global mRNA Cancer Vaccines and Therapeutics Market
The global mRNA Cancer Vaccines and Therapeutics market size is projected to reach US$ 780.5 million by 2026, from US$ 213.7 million in 2020, at a CAGR of 24.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global mRNA Cancer Vaccines and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global mRNA Cancer Vaccines and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global mRNA Cancer Vaccines and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global mRNA Cancer Vaccines and Therapeutics market.

Global mRNA Cancer Vaccines and Therapeutics Scope and Market Size
mRNA Cancer Vaccines and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Cancer Vaccines and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas

Market segment by Application, split into
Infectious Disease
Cancer
Other

Based on regional and country-level analysis, the mRNA Cancer Vaccines and Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global mRNA Cancer Vaccines and Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2015-2026)
2.2 Global mRNA Cancer Vaccines and Therapeutics Growth Trends by Regions
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Market Size
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2019
3.5 Key Players mRNA Cancer Vaccines and Therapeutics Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2021-2026)

5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2015-2026)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2015-2026)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

(2015-2020)
(2015-2020)
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
(2015-2020)
(2015-2020)
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 mRNA Cancer Vaccines and Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
8Key Players Profiles
8.1 Moderna Therapeutics
8.1.1 Moderna Therapeutics Company Details
8.1.2 Moderna Therapeutics Business Overview
8.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020))
8.1.5 Moderna Therapeutics Recent Development
8.2 CureVac
8.2.1 CureVac Company Details
8.2.2 CureVac Business Overview
8.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
8.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.2.5 CureVac Recent Development
8.3 Translate Bio
8.3.1 Translate Bio Company Details
8.3.2 Translate Bio Business Overview
8.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
8.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.3.5 Translate Bio Recent Development
8.4 BioNTech
8.4.1 BioNTech Company Details
8.4.2 BioNTech Business Overview
8.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
8.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.4.5 BioNTech Recent Development
8.5 Sangamo Therapeutics
8.5.1 Sangamo Therapeutics Company Details
8.5.2 Sangamo Therapeutics Business Overview
8.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.5.5 Sangamo Therapeutics Recent Development
8.6 Argos Therapeutics
8.6.1 Argos Therapeutics Company Details
8.6.2 Argos Therapeutics Business Overview
8.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
8.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.6.5 Argos Therapeutics Recent Development
8.7 In-Cell-Art
8.7.1 In-Cell-Art Company Details
8.7.2 In-Cell-Art Business Overview
8.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
8.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.7.5 In-Cell-Art Recent Development
8.8 eTheRNA
8.8.1 eTheRNA Company Details
8.8.2 eTheRNA Business Overview
8.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
8.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.8.5 eTheRNA Recent Development
8.9 Ethris
8.9.1 Ethris Company Details
8.9.2 Ethris Business Overview
8.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
8.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.9.5 Ethris Recent Development
8.10 Tiba Biotechnology
8.10.1 Tiba Biotechnology Company Details
8.10.2 Tiba Biotechnology Business Overview
8.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
8.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
8.10.5 Tiba Biotechnology Recent Development

9Analyst’s Viewpoints/Conclusions

10Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Disclaimer
10.3 Author Details

List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Adeno Carcinomas
Table 4. Key Players of Mucinous Carcinomas
Table 5. Key Players of Adenosquamous Carcinomas
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2015-2020)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2021-2026)
Table 12. mRNA Cancer Vaccines and Therapeutics Market Market Trends
Table 13. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 14. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 15. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 16. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2015-2020)
Table 18. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2019)
Table 19. Global mRNA Cancer Vaccines and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Type (2015-2020)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2021-2026)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2015-2020)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size Share by Application (2021-2026)
Table 29. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 31. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Share by Country (2015-2020)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2015-2020)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2015-2020)
Table 39. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Country (2015-2020)
Table 41. mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 42. mRNA Cancer Vaccines and Therapeutics Market Share by Region (2015-2020)
Table 43. mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 44. mRNA Cancer Vaccines and Therapeutics Market Share by Country (2015-2020)
Table 45. mRNA Cancer Vaccines and Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 46. mRNA Cancer Vaccines and Therapeutics Market Share by Country (2015-2020)
Table 47. Moderna Therapeutics Company Details
Table 48. Moderna Therapeutics Business Overview
Table 49. Moderna Therapeutics Product
Table 50. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 51. Moderna Therapeutics Recent Development
Table 52. CureVac Company Details
Table 53. CureVac Business Overview
Table 54. CureVac Product
Table 55. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 56. CureVac Recent Development
Table 57. Translate Bio Company Details
Table 58. Translate Bio Business Overview
Table 59. Translate Bio Product
Table 60. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 61. Translate Bio Recent Development
Table 62. BioNTech Company Details
Table 63. BioNTech Business Overview
Table 64. BioNTech Product
Table 65. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 66. BioNTech Recent Development
Table 67. Sangamo Therapeutics Company Details
Table 68. Sangamo Therapeutics Business Overview
Table 69. Sangamo Therapeutics Product
Table 70. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 71. Sangamo Therapeutics Recent Development
Table 72. Argos Therapeutics Company Details
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics Product
Table 75. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 76. Argos Therapeutics Recent Development
Table 77. In-Cell-Art Company Details
Table 78. In-Cell-Art Business Overview
Table 79. In-Cell-Art Product
Table 80. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 81. In-Cell-Art Recent Development
Table 82. eTheRNA Business Overview
Table 83. eTheRNA Product
Table 84. eTheRNA Company Details
Table 85. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 86. eTheRNA Recent Development
Table 87. Ethris Company Details
Table 88. Ethris Business Overview
Table 89. Ethris Product
Table 90. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 91. Ethris Recent Development
Table 92. Tiba Biotechnology Company Details
Table 93. Tiba Biotechnology Business Overview
Table 94. Tiba Biotechnology Product
Table 95. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2015-2020) (US$ Million)
Table 96. Tiba Biotechnology Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Adeno Carcinomas Features
Figure 3. Mucinous Carcinomas Features
Figure 4. Adenosquamous Carcinomas Features
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Infectious Disease Case Studies
Figure 7. Cancer Case Studies
Figure 8. Other Case Studies
Figure 9. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 10. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Share by Regions (2021-2026)
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2019
Figure 14. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2019
Figure 16. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 44. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 45. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 46. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 47. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 48. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 49. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 50. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 51. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 52. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

---